Post Mon Dec 02, 2024 6:42 pm

2024-Zhu et al-Nat Commun

"Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial"
Yu-Chun Zhu, Zhi-Gong Wei, Jing-Jing Wang, Yi-Yan Pei, Jing Jin, Dong Li, Zhi-Hui Li, Zhe-Ran Liu, Yu Min, Rui-Dan Li, Li Yang, Ji-Yan Liu, Qiang Wei, Xing-Chen Peng
Nat Commun. 2024, 15, 10371
https://doi.org/10.1038/s41467-024-54661-9

- no CyTOF dataset accession given